A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression
Status:
Active, not recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of esketamine nasal spray
in participants with treatment-resistant depression (TRD).